|
26 Jan 2012
NeurOp Awarded Deal of the Year for Ischemia Program Funding
NeurOp, Inc. was recognized by Georgia Bio with a Deal of the Year Award for its $3 million Small Business Innovation Research (SBIR) grant from the National Institutes of Health to support its resear ...
Read More
|
14 Dec 2011
NeurOp Announces Extension to Drug Discovery Collaboration with Bristol-Myers Squibb
ATLANTA, December 14, 2011 - NeurOp, Inc. today announced that Bristol-Myers Squibb (NYSE: BMY) has agreed to fund an additional year of research for NeurOp's proprietary small molecules for the treat ...
Read More
|
18 Oct 2011
NeurOp Selected for NIH Commercialization Assistance Program to Support Drug Development Efforts for Ischemia
ATLANTA, October 18, 2011 – NeurOp, Inc., a biopharmaceutical company developing new treatments for central nervous system disorders, today announced that it is one of 40 companies selected to partici ...
Read More
|
26 Jul 2011
NeurOp Awarded $3 Million NIH Grant for Ischemia Treatment Research
ATLANTA, July 26, 2011 – NeurOp, Inc., a biopharmaceutical company developing new treatments for central nervous system disorders,
today announced that the National Institutes of Health (NIH) has aw ...
Read More
|
22 Jun 2011
Robert Bonczek Joins NeurOp Board of Directors
ATLANTA, June 22, 2011 - NeurOp Corporation today announced that Robert R. Bonczek has been elected to the company's board of directors. He is president, CFO and general counsel at b3bio, Inc., a biot ...
Read More
|
|